Beauty Bioscience Expanding to Sephora, Adds Rose Quartz Roller

Beauty Bioscience is headed to Sephora.The maker of GloPro — the cult at-home microneedling tool — is entering the retailer in September, launching first online and rolling out to stores for holiday. Sephora will carry the GloPro device and Beauty Bioscience’s line of topical skin care, which launched last year.The company is in a period of rapid retail expansion, moving into all Neiman Marcus and Nordstrom doors in the past year. Beauty Bioscience launch in Selfridge’s in the U.K. in July, Douglas in Germany in October and Space N.K. stores in January. Industry sources estimate that with the additional distribution, the brand could easily hit more than $100 million in retail sales by the end of the year. Topical skin-care sales are growing significantly, and are beginning to outpace those of the GloPro tool, sources close Beauty Bioscience say.The company is also broadening its tool assortment, introducing in July a rose quartz roller and a rose quartz roller attachment, designed to fit with a GloPro base. A stand-alone roller retailers for $60 and the attachment is priced at $45.Crystal-based rollers like the jade roller and rose quartz roller — skin-care tools said to be used in ancient skin-care rituals — are having an Instagram-fueled moment. Pinterest searches for facial rollers were up 345 percent in 2017, according to the platform. Beauty Bioscience founder and chief executive officer Jamie O’Banion said she has been inundated with requests to come out with a Beauty Bioscience roller. Healing crystals don’t match O’Banion’s science-backed MO, but she knew that GloPro users were buying crystal rollers and with the roller attachment, she knew she had a compelling two-for-one product.”I started seeing so many influencers — Eva Chen, Tan France, Patrick Ta — using our tool,” said O’Banion. “I started seeing this trend of them the GloPro right next to their jade rollers — frees up space.”Beauty Bioscience will launch another tool in 2019, though O’Banion could not talk specifics.

Source: Read Full Article